The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASCO GI 2021 | Landscape of actionable somatic alterations in advanced CCA

Name: Landscape of actionable somatic alterations in advanced CCA
Uploaded: 2021-01-18T00:00:00Z
Duration: 4 min 37 s
Description: Pashtoon M. Kasi, MD, MS, University of Iowa, Iowa City, IA, discusses the results of an investigation aiming to characterize genomic alterations that are linked to targeted therapies to facilitate a personalized approach to the treatment and management of cholangiocarcinoma (CCA). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Pashtoon M. Kasi • 18 Jan 2021

ASCO GI 2021

Bile Duct Cancer Gastrointestinal Cancer

Pashtoon M. Kasi, MD, MS, University of Iowa, Iowa City, IA, discusses the results of an investigation aiming to characterize genomic alterations that are linked to targeted therapies to facilitate a personalized approach to the treatment and management of cholangiocarcinoma (CCA). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).